A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals

Journal of Crohn's and Colitis

Volumn 13, Issue 5, 2019, Pages 648-658

  Kakuta, Yoichi ^a   Kawai, Yosuke ^b   Naito, Takeo ^a   Hirano, Atsushi ^c   Umeno, Junji ^c   Fuyuno, Yuta ^c   Liu, Zhenqiu ^d   Li, Dalin ^d   Nakano, Takeru ^a   Izumiyama, Yasuhiro ^a   Ichikawa, Ryo ^a   Okamoto, Daisuke ^a   Nagai, Hiroshi ^a   Matsumoto, Shin ^a   Yamamoto, Katsutoshi ^a   Yokoyama, Naonobu ^a   Chiba, Hirofumi ^a   Shimoyama, Yusuke ^a   Onodera, Motoyuki ^a   Moroi, Rintaro ^a   Kuroha, Masatake ^a   Kanazawa, Yoshitake ^a   Kimura, Tomoya ^a   Shiga, Hisashi ^a   Endo, Katsuya ^a   Negoro, Kenichi ^a   Yasuda, Jun ^b   Esaki, Motohiro ^c   Tokunaga, Katsushi ^e   Nakamura, Minoru ^f   Matsumoto, Takayuki ^c,g   McGovern, Dermot P B ^d   Nagasaki, Masao ^b   Kinouchi, Yoshitaka ^b   Shimosegawa, Tooru ^a   Masamune, Atsushi ^a   more..

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^g IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Crohn's disease; RAP1A; susceptibility gene

Indexed keywords

HLA DQB1 ANTIGEN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; RAP1 PROTEIN; RAP1A PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC BACKGROUND; GENETIC SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION STUDY; HLA DQB1 GENE; HUMAN; JAPAN; JAPANESE (PEOPLE); LAMINA PROPRIA; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; RAP1A GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TNFSF15 GENE; TRANSCRIPTOMICS; ADULT; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; MALE; PHYSIOLOGY; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JAPAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RAP1 GTP-BINDING PROTEINS; YOUNG ADULT;

EID: 85068490457     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjy197     Document Type: Article

References (52)

1. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42:1118-25.
2. Jostins L, Ripke S, Weersma RK, et al.; International IBD Genetics Consortium [IIBDGC]. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-24.
3. Liu JZ, van Sommeren S, Huang H, et al.; International Multiple Sclerosis Genetics Consortium; International IBD Genetics Consortium. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47:979-86.
4. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011;13:101.
5. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine- rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
6. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
7. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
8. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47:469-72.
9. Yamazaki K, Onouchi Y, Takazoe M, Kubo M, Nakamura Y, Hata A. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet 2007;52:575-83.
10. Hirano A, Yamazaki K, Umeno J, et al. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis 2013;19:526-33.
11. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005;14:3499-506.
12. Kakuta Y, Kinouchi Y, Negoro K, Takahashi S, Shimosegawa T. Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut 2006;55:1527-8.
13. Nagasaki M, Yasuda J, Katsuoka F, et al.; ToMMo Japanese Reference Panel Project. Rare variant discovery by deep whole-genome sequencing of 1070 Japanese individuals. Nat Commun 2015;6:8018.
14. Kawai Y, Mimori T, Kojima K, et al. Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals. J Hum Genet 2015;60:581-7.
15. Kuriyama S, Yaegashi N, Nagami F, et al. The Tohoku medical megabank project: design and mission. J Epidemiol 2016;26:493-511.
16. Kakuta Y, Kawai Y, Okamoto D, et al. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. J Gastroenterol 2018, Jun 19. doi: 10.1007/s00535-018-1486-7. [Epub ahead of print.]
17. Matsui T, Hirai F, Hisabe T. Proposed diagnostic criteria for Crohn's disease. Annual reports of the research group of intractable inflammatory bowel disease granted by the Ministry of Health, Labour, and Welfare of Japan. 2011; 52-4.
18. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53.
19. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Secondgeneration PLINK: rising to the challenge of larger and richer datasets. Gigascience 2015;4:7.
20. Staples J, Nickerson DA, Below JE. Utilizing graph theory to select the largest set of unrelated individuals for genetic analysis. Genet Epidemiol 2013;37:136-41.
21. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
22. Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods 2011;9:179-81.
23. Fiocchi C, Youngman KR. Isolation of human intestinal mucosal mononuclear cells. Curr Protoc Immunol 2001;Chapter 7:Unit 7.30.
24. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 2011;17:10-2.
25. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011;27:863-4.
26. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009;25:1105-11.
27. Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010;28:511-5.
28. Turner SD. Qqman: an R package for visualizing GWAS results using Q-Q and Manhattan plots. bioRxiv 005165 2014. http://biorxiv.org/content/ early/2014/05/14/005165.abstract
29. Pruim RJ, Welch RP, Sanna S, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010;26:2336-7.
30. Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 2017;45:D362-8.
31. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.
32. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995;109:1462-7.
33. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 1999;53:350-8.
34. Yang SK, Hong M, Zhao W, et al. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut 2014;63:80-7.
35. Yamazaki K, Takahashi A, Takazoe M, et al. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients. Gut 2009;58:228-32.
36. Kakuta Y, Kimura T, Negoro K, et al. Increased expression of IL12b mRNA transcribed from the risk haplotype for Crohn's disease is a risk factor for disease relapse in Japanese patients. J Gastroenterol 2017;52(12):1230-9.
37. Kim SW, Kim ES, Moon CM, et al. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 2011;60:1527-36.
38. Onodera K, Arimura Y, Isshiki H, et al. Low-frequency IL23R coding variant associated with Crohn's disease susceptibility in Japanese subjects identified by personal genomics analysis. PLoS One 2015;10:e0137801.
39. Hong SN, Park C, Park SJ, et al.; IBD Study Group of the Korean Association for the Study of Intestinal Diseases [KASID]. Deep resequencing of 131 Crohn's disease associated genes in pooled DNA confirmed three reported variants and identified eight novel variants. Gut 2016;65:788-96.
40. Barrett JC, Hansoul S, Nicolae DL, et al.; NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-62.
41. Yamazaki K, Umeno J, Takahashi A, et al. A genome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population. Gastroenterology 2013;144:781-8.
42. Yang SK, Hong M, Choi H, et al. Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans. Inflamm Bowel Dis 2015;21:1-7.
43. Abecasis GR, Altshuler D, Auton A, et al.; 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.
44. Auton A, Brooks LD, Durbin RM, et al.; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 2015;526:68-74.
45. Ishihara S, Nishikimi A, Umemoto E, Miyasaka M, Saegusa M, Katagiri K. Dual functions of Rap1 are crucial for T-cell homeostasis and prevention of spontaneous colitis. Nat Commun 2015;6:8982.
46. Westra HJ, Arends D, Esko T, et al. Cell specific eQTL analysis without sorting cells. PLoS Genet 2015;11:e1005223.
47. Aguet F, Brown AA, Castel S, et al. Local genetic effects on gene expression across 44 human tissues. bioRxiv 074450 2016.
48. Wittchen ES, Aghajanian A, Burridge K. Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions. Small GTPases 2011;2:65-76.
49. Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013;369:711-21.
50. Ghosh S, Goldin E, Gordon FH, et al.; Natalizumab Pan-European Study Group. Natalizumab for active Crohn's disease. N Engl J Med 2003;348:24-32.
51. Luthra P, Peyrin-Biroulet L, Ford AC. Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with antiintegrin antibodies in inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:1227-36.
52. Huang H, Fang M, Jostins L, et al.; International Inflammatory Bowel Disease Genetics Consortium. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 2017;547:173-8.